"I know that I know nothing","The only thing I know, is that I know nothing"
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This company*
That was a lot of typing to simply state you care about these companies and its potential. My work here is done.
I'm not exactly following. How has this reverted back to Jim. The last 8k states this has currently went to someone else and there is nothing to show yet that states otherwise, correct?
So, you believe JK to be a disingenuous charlatan and the chart speaks for yourself. So, riddle me this, why do you still care?
Not sure you can get much more accomplished than him.
Dude. You are ridiculous.
Well, regardless , you are highly interested seeing you are here wasting your important breath posting.
Do you have any skin in the game here?
Without a doubt. Should be in a different realm at that point.
Stop it
Lot of insecurities you have.
That is just the money it has been given. Not including the equipment, software, patents, FDA , and personnel, it is most definitely worth more.
That is not what you stated stud muffin. You stated you LOOOOOOOOOOOOVVVVVVVVVVVVVVEEEEEEEEEEEEEEEEEEE GSTC! WWWWWWWWWWWWWWWWWWEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEE
Reminds me of a certain someone who would scream... weeeeeeeeeeeeeeeee
But you love GSTC, right? Or were you just lying. I could go all day through your posts and find lies.
I wish I had that power. He somehow lost his ass and doesnt have shares. Other than that, he is trying extremely hard to piss people off and ihub is continually allowing it. I have had to personally remove many of his posts because they were personal. Clearly, there is some open allowance now with what you can and cannot say and us users do not clearly know what the heck that is.
We all know the moon landing is fake and so is everything people do. God forbid there were institutions and agencies that monitored and provided details to trials, haha. But we all know that would be fake as well.
BOOOOMM TTTIIIIIIMMMMMME!
Maybe. You have no idea how much higher the OS will get. Additionally, with the drug potentials and where it may go, we will probably encounter a RS. None of that remotely matters with the magnitude that is potentially offered here if the results are what we see. Shares are almost erroneous when talking about biotechs.
I'm just optimistic with those people helping run the company. I believe they are capable people and there is no point in thinking about this short-term. I never have. I think we should be further along in the process, but it is what it is.
I agree with this statement.
Well, form some it happens.
I have no clue what you are saying.
Good question. The toxicity study would be used to test the toxicity of the combination of the already approved FDA drugs. I do not exactly know. I would expect they run the rodent study for the length of the therapy, then maybe a week or 2 longer to response after the drug moves through the animal and to test accordingly.
But because it's the same drug being ingested consistently every day, they could shorten it. We know the protocol lasts 42-45 days to achieve the optimal results. But those in control of the study may not require nearly that long to test for toxicity of the drug therapy. So, it's hard to know. I would venture to say the length of the protocol or close to it. 4-8 weeks. Just my guess.
They will probably have to conduct a toxicity study before the clinical trial to test the toxicity of the drug. But we will find out.
Jim never diluted. What are you talking about?
Correct. I do not think anyone would be shocked by that. It requires some sort of financing to stay alive as its aim is clinical trials and beyond.
This is helpful. Actually very helpful. It means only Power Up sold and that 50.9 mill D preferred hasn't hit the float.
This is good.
Could be a certain lender or flipper or whomever. People always have narratives.
Correct. The Italian study was conducted in 2014 timeframe and made it through Phase 2 trials. Really, the only reason why it didn't go Phase 3 is because Fabrizio and the principal investigator was doing it illegally. Remember, there were articles of interest from Pfizer, Roche, and alike. Italy is not friendly when it comes to pharmaceuticals and has a reputation for bureaucratic delays and doing shady things. It was something Fabrizio especially mentioned.
In order to pursue the therapy to help others, he had to file a patent in the US in 2015. Which was granted in 2020.... and now here we are:
https://patents.justia.com/inventor/fabrizio-de-silvestri
https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(19)30229-4/fulltext
In regard to the science advancing a lot, it has but not in this area. Some drug just recently came out, but to only help very specific MS patients. So, not sure what you are talking about. What Jim decided to do with the G Preferred, I expect is for the company. If not, he opens himself up to lawsuits, which people and companies will win. If Jim just wanted to take the money, he could have just taken the cool $1,000,000 and sold shares relentlessly.
Anyway, those are just assumptions you are making without any hard data.
Great question. The compounds that are out on the market like you or I use have several uses and affect the body in many ways. Many of which are never tested because there isn't enough data out there to warrant further testing that would be profitable to pharmaceutical companies. Institutions like NIH are a great resource, and neighboring institutes or institutions that are looking to solve very difficult problems in target diseases.
Without going in depth, these three drugs have alternate uses as shown by research I have provided, all of which have shown benefits to the reduction of certain physiological changes in the body occurring in those suffering from Multiple Sclerosis. What makes this unique is that Fabrizio found already FDA approved marketed drugs, that reduce various symptomology of MS in those that are suffering or living with the condition. With the right combination of each drug within the solution given to patients, can dramatically improve their motor and dexterity, and more.
It's the combination of the drugs working together to reduce neurophysiological symptoms that allow people suffering from MS to live much more productive lives. It's just that no one has done this or found this out. Italian trial data supposedly shows the 150-person trial and the results of those trials.
So, that is why it will get funding for trials. Jim probably could have gotten funding a long time ago, but I am assuming Jim doesn't want to dilute or give away too much of the company, who knows.
So, in totality, I just gave everyone here research from major resources showing the reality these drugs have shown in regard to MS individually, it's not very difficult to make a leap that a combinational therapy could have potential as.... a therapy, to allow patients to live a better life.
And. while you are at it. You should dive deep into statin research, or Atorvastatin, which has research found to protect the brain from deterioration from neurodegeneration of lets say multiple sclerosis.
Multiple sclerosis (MS) is a chronic disease that affects the central nervous system (CNS). Currently, there is no cure for MS. However, research suggests that statins may be a promising potential treatment option for the disease.
MS is a condition that affects the CNS and can result in a range of symptoms throughout the body. Some research suggests that 250,000–350,000Trusted Source people in the United States are living with MS, while other sources estimate the number is closer to 1 million.
Statins refer to a group of drugs that help lower blood cholesterol levels. While research on statins and MS is still in the early stages, evidence indicates promise in using this class of drugs to treat the condition.
You should also read this about antifungals like Fluconazole, or I should say, the antifungal that NIH has found to be responsive for further examination in multiple sclerosis treatments:
Two drugs already on the market — an antifungal and a steroid — may potentially take on new roles as treatments for multiple sclerosis. According to a study published in Nature today, researchers discovered that these drugs may activate stem cells in the brain to stimulate myelin producing cells and repair white matter, which is damaged in multiple sclerosis. The study was partially funded by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health.
Read: https://en.wikipedia.org/wiki/Minocycline (Research)
Early research has found a tentative benefit from minocycline in schizophrenia,[50] with several trials underway.[51] A 2014 meta-analysis found minocycline may reduce negative and total symptom scores and was well tolerated.[52]
Research is examining the possible neuroprotective and anti-inflammatory effects of minocycline against the progression of a group of neurodegenerative disorders including multiple sclerosis, rheumatoid arthritis, Huntington's disease, and Parkinson's disease.[53][54][55][56] As mentioned above, minocycline harms ALS patients.
You are very right. Let's hope we see everything align. I spoke to a lot of people. Including patent owner. Just some more patience!
Welcome. Seems like you have been fortunate to miss the past 3 years and coming in for the soon to be best part.
These individuals know what they are doing. Either he is an idiot poster or paid. Doesnt really matter. But they use the same old elementary school tactics
I expect with Spivak behind the reigns, we will get the funding we require
So, why is it you are here talking about this one fact? Seems to me your revolving shpeel!?